{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:46:52Z","timestamp":1785246412023,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>The epidemiology of bacterial pathogens causing bloodstream infections (BSIs) in pediatric hematology\/oncology patients is changing and resistance to antimicrobial agents is globally spread. We retrospectively assessed demographic, clinical, and microbiologic data of BSIs during a 5-year period at a pediatric hematology\/oncology unit from January 1, 2017, to December 31, 2021, at the University Hospital Centre Zagreb, Zagreb, Croatia. In 66 pediatric patients with malignancies, 93 BSI episodes were registered and 97 bacterial isolates were cultured. The Gram-positive versus Gram-negative ratio was 67 (69.1%) versus 30 (30.9%). Coagulase-negative staphylococci (48; 49.6%) were the most frequent isolates, followed by Enterobacterales (17; 17.5%) and <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (6; 6.2%). Multidrug resistance isolates included extended spectrum \u03b2-lactamase producers (n=3). Resistance rates to piperacillin\/tazobactam, cefepime, and meropenem in Gram-negative isolates were 15.4%, 14.3%, and 0.0%, respectively. Gram-positive bacteria are the most common cause of BSI in our patients. Resistance rates to piperacillin\/tazobactam and cefepime in Gram-negative isolates make meropenem a better choice for empirical antimicrobial treatment. As national and hospital data may differ, the surveillance of pathogen distribution and antimicrobial susceptibility in pediatric hematology\/oncology wards is necessary to adjust empirical treatment accordingly.<\/jats:p>","DOI":"10.1097\/mph.0000000000002809","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:00:10Z","timestamp":1705590010000},"page":"e156-e163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Bloodstream Infections in Pediatric Oncology Patients: Bacterial Pathogen Distribution and Antimicrobial Susceptibility at the University Hospital Centre Zagreb, Croatia\u2014A 5-Year Analysis"],"prefix":"10.1097","volume":"46","author":[{"given":"Ivana","family":"Marekovi\u0107","sequence":"first","affiliation":[{"name":"Clinical Department of Clinical Microbiology, Infection and Prevention Control, University Hospital Centre Zagreb"},{"name":"Department of Medical Microbiology and Parasitology, School of Medicine University of Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajana","family":"Vujnovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Andrija \u0160tampar Teaching Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Radanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Institute of Public Health Zagreb County"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Herljevi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Department of Clinical Microbiology, Infection and Prevention Control, University Hospital Centre Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Kuli\u0161","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital Centre Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Pavlovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, University Hospital Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"Mucavac","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, University Hospital Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dejanovi\u0107-Beki\u0107","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, University Hospital Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Bili\u0107","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, University Hospital Zagreb"},{"name":"Department of Pediatrics, School of Medicine University of Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/MPH.0000000000002253","article-title":"Predictive factors for Gram-negative versus Gram-positive bloodstream infections in children with cancer","volume":"44","author":"Sfetsiori","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/jcm11030880","article-title":"Characteristics and outcomes of bloodstream infections in a tertiary-care pediatric hematology-oncology unit: a 10-year study","volume":"11","author":"Mattei","year":"2022","journal-title":"J Clin Med"},{"issue":"suppl 4","key":"R3-20250804","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"R5-20250804","first-page":"2417","article-title":"Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia\u2014species distribution and susceptibility patterns","volume":"21","author":"Miedema","year":"2013","journal-title":"Support Care Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH\/ESCMID. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J Infect"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPH.0b013e318257a6ca","article-title":"Vancomycin-resistant Enterococcus in pediatric oncology patients: balancing infection prevention and family-centered care","volume":"35","author":"Singh","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"e13610","DOI":"10.1111\/petr.13610","article-title":"Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations","volume":"24","author":"Youssef","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.17219\/acem\/69003","article-title":"Frequency of isolation and drug susceptibility of bacterial strains isolated from child oncohematological patients 2011-2014: a single center study","volume":"27","author":"Kowalska-Krochmal","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/IDR.S70486","article-title":"Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology\/oncology patients after anticancer chemotherapy","volume":"7","author":"Al-Mulla","year":"2014","journal-title":"Infect Drug Resist"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/MPH.0000000000002258","article-title":"Bloodstream infections in children with cancer: pathogen distribution and antimicrobial susceptibility patterns over a 10-year period","volume":"44","author":"Maarbjerg","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"e0246654","DOI":"10.1371\/journal.pone.0246654","article-title":"Pediatric fever in neutropenia with bacteremia\u2014pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study","volume":"16","author":"Stergiotis","year":"2021","journal-title":"PLoS One"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric febrile neutropenia: change in etiology of bacteremia, empiric choice of therapy and clinical outcomes","volume":"42","author":"Alali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","article-title":"Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"100","author":"B\u00f6ll","year":"2021","journal-title":"Ann Hematol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3906\/sag-1812-101","article-title":"Bloodstream infections in pediatric hematology\/oncology patients: six years\u2019 experience of a single center in Turkey","volume":"49","author":"Tural Kara","year":"2019","journal-title":"Turk J Med Sci"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1871525721666221125093836","article-title":"Clinical characteristics and risk factors for bloodstream infections in children with cancer: a report from a Pediatric Hematology Oncology Unit","volume":"21","author":"Bangeas","year":"2023","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/mdr.2021.0256","article-title":"Bacteremia in children with solid tumors: etiology, antimicrobial susceptibility, factors associated with multidrug resistance, and mortality","volume":"28","author":"Ginzburg","year":"2022","journal-title":"Microb Drug Resist"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4103\/0019-509X.175364","article-title":"Epidemiology of bacterial isolates among pediatric cancer patients from a tertiary care oncology center in North India","volume":"51","author":"Kapoor","year":"2014","journal-title":"Indian J Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4103\/0366-6999.213411","article-title":"Clinical characteristics of bloodstream infections in pediatric acute leukemia: a single-center experience with 231 patients","volume":"130","author":"Yao","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00277-021-04541-9","article-title":"Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis","volume":"100","author":"Weber","year":"2021","journal-title":"Ann Hematol"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"e2952","DOI":"10.1097\/MD.0000000000002952","article-title":"Viridans group streptococcal infections in children after chemotherapy or stem cell transplantation: a 10-year review from a tertiary pediatric hospital","volume":"95","author":"Nielsen","year":"2016","journal-title":"Medicine"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MPH.0000000000001878","article-title":"Outcomes and disposition of oncology patients with non-neutropenic fever and positive blood cultures","volume":"43","author":"Sharma","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/antibiotics11070900","article-title":"Infections during non-neutropenic episodes in pediatric cancer patients\u2014results from a prospective study in two major large European cancer centres","volume":"11","author":"Sch\u00f6ning","year":"2022","journal-title":"Antibiotics"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10238-023-01206-x","article-title":"Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years","volume":"23","author":"Peri","year":"2023","journal-title":"Clin Exp Med"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pbc.22264","article-title":"Bacteremia in febrile nonneutropenic pediatrc oncology patients","volume":"54","author":"Kelly","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jpids\/piu014","article-title":"Systematic review of antibiotic resistance rates among Gram-negative bacteria in children with sepsis in resource-limited countries","volume":"4","author":"Le Doare","year":"2015","journal-title":"J Ped Infect Dis Soc"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"e0028321","DOI":"10.1128\/Spectrum.00283-21","article-title":"Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020","volume":"9","author":"Fu","year":"2021","journal-title":"Microbiol Spectr"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"752037","DOI":"10.3389\/fonc.2021.752037","article-title":"Stenotrophomonas maltophilia infections in pediatric patients\u2014experience at a European Center for Pediatric Hematology and Oncology","volume":"11","author":"Z\u00f6llner","year":"2021","journal-title":"Front Oncol"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"ofab644","DOI":"10.1093\/ofid\/ofab644","article-title":"Trimethoprim-sulfamethoxazole versus levofloxacin for Stenotrophomonas maltophilia infections: a retrospective comparative effectiveness study of electronic health records from 154 US hospitals","volume":"9","author":"Sarzynski","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/antibiotics10101226","article-title":"Antimicrobial treatment strategies for Stenotrophomonas maltophilia: a focus on novel therapies","volume":"10","author":"Gibb","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"e0152132","DOI":"10.1371\/journal.pone.0152132","article-title":"Evaluation of trimethoprim\/sulfamethoxazole (SXT), minocycline, tigecycline, moxifloxacin, and ceftazidime alone and in combinations for SXT-susceptible and SXT-resistant Stenotrophomonas maltophilia by in vitro time-kill experiments","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS One"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmi.2021.09.039","article-title":"Culture-independent detection systems for bloodstream infection","volume":"28","author":"Peri","year":"2022","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:04:33Z","timestamp":1754337873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002809","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"assertion":[{"value":"2023-03-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}